Why REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

Por um escritor misterioso

Last updated 25 março 2025

Why REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

Learn more about REXULTI for agitation that may happen with dementia due to Alzheimer’s disease. See Important Safety Info and Full Prescribing Info, including Boxed WARNING.

These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015

REXULTI®(brexpiprazole)

Brexpiprazole Warnings: Side Effects of Rexulti

Otsuka, Lundbeck's sNDA for Rexulti received US FDA approval

Agitation in Alzheimer's: Rexulti® Makes Meaningful Improvements

JAMA Neurology Publishes Complete Results of Positive Phase 3 Study of REXULTI® (brexpiprazole) for Agitation Associated with Dementia Due to Alzheimer's Disease

Psych News Alert: FDA Approves Rexulti for Agitation Associated With Dementia Due to Alzheimer's Disease

Pyrls on Instagram: Brexpiprazole's (REXULTI) new indication makes it the first FDA-approved option for agitation associated with dementia due to Alzheimer's disease ✨ Learn more about brexpiprazole in your Pyrls app or

Medications for Memory Loss

REXULTI® (brexpiprazole) Patient Information Website

FDA rushes approval of dementia drug that quadruples risk of death

Recomendado para você